Search Results (1,076)

Acorns (Quercus spp.) are an underutilized forest resource with recognized nutritional and bioactive potential, making them promising candidates for the development of sustainable plant-based functional foods. This study aimed to valorize acorns through the formulation of two novel acorn-based products, a plant-based beverage, and a pudding, and to assess their nutritional properties, sensory acceptability, and, for the beverage, refrigerated shelf-life stability. The beverage was optimized as a neutral-flavored milk alternative, using sodium alginate as a natural clean-label stabilizer to enhance emulsion stability and physicochemical properties. The final formulation exhibited low energy density and a lipid profile rich in monounsaturated fatty acids, contributing to its nutritional and functional value. Throughout 63 days of storage at 4 °C, sodium alginate effectively prevented phase separation and supported the retention of antioxidant capacity, as evidenced by stable ferric reducing antioxidant power (FRAP) and total phenolic content, although ABTS radical scavenging activity declined over time. No microbial growth was detected during storage, confirming the adequacy of the applied thermal treatment and aseptic filling procedures applied. The acorn-based pudding, developed by adapting a traditional egg-based recipe, functioned as a proof of concept illustrating the technological versatility of acorns across distinct plant-based matrices, exhibiting a nutritional profile comparable to commercial counterparts and high consumer acceptability. Overall, this work demonstrates the technological feasibility and versatility of incorporating acorns into plant-based food matrices, supporting their potential as sustainable ingredients for the development of innovative value-added foods and contributing to the valorization of forest resources. Full article

Background: Oral delivery of chemotherapeutic agents remains challenging due to gastrointestinal degradation, poor intestinal permeability, and extensive first-pass metabolism, which collectively limit bioavailability. Lipid-based drug delivery systems offer a promising strategy to overcome these barriers. This study aimed to develop a freeze-dried, solid-dispersible self-emulsifying drug delivery system (SEDDS) using a water-in-oil-in-water (w/o/w) double emulsion approach for the co-encapsulation of hydrophilic (doxorubicin) and lipophilic (ellipticine) agents to enhance oral delivery. Methods: Double-emulsion SEDDS were prepared via a two-stage emulsification process to enable compartmentalized drug loading within aqueous and oil phases. The formulations were freeze-dried to improve stability and storage. Physicochemical properties were characterized using dynamic light scattering for droplet size and polydispersity index (PDI), zeta potential analysis for colloidal stability, and differential scanning calorimetry for thermal behavior. Drug encapsulation efficiency was determined, and cellular uptake was evaluated in breast cancer cells using fluorescence microscopy. Results: Optimized SEDDS exhibited droplet sizes of 90–347 nm with low PDI values (0.005–0.336), indicating uniform and stable dispersions. Zeta potential values (−10.64 to 2.38 mV) supported colloidal stability, while freeze-dried formulations retained dispersion characteristics upon reconstitution over extended storage. Both drugs demonstrated high encapsulation efficiency (>97%), and thermal analysis confirmed the formation of stable amorphous systems. Fluorescence imaging revealed enhanced intracellular uptake of both agents. Conclusions: This study demonstrates that freeze-dried double-emulsion SEDDS enable efficient co-delivery of hydrophilic and lipophilic drugs, improving stability and cellular uptake. This platform shows strong potential for overcoming key barriers in oral chemotherapy and provides a promising strategy for combination drug delivery. Full article

Aristotelia chilensis (maqui berry) is a Chilean native fruit rich in anthocyanins with potential antioxidant, glycemic, cardiometabolic, and ocular benefits, but its clinical efficacy remains unclear. This systematic review synthesized and critically appraised human trials evaluating oral maqui supplementation in adults. Following PRISMA 2020 and a PROSPERO-registered protocol, five databases were searched, and risk of bias and certainty of evidence were assessed using RoB 2/ROBINS-I and GRADE. Twelve clinical trials published between 2014 and 2023 were included. Acute studies consistently showed reduced postprandial glucose and modulation of insulin response, whereas chronic interventions showed modest and inconsistent effects on HbA1c, lipid profile, and other cardiometabolic markers. Favorable changes were also reported for oxidative stress biomarkers and autonomic parameters, although these findings were mainly based on surrogate endpoints. The most consistent evidence was observed in the ocular domain, where maqui supplementation improved tear production, dry eye symptoms, and tear inflammatory markers. The overall certainty of evidence ranged from moderate to very low because of methodological heterogeneity, small sample sizes, and short intervention duration. Maqui berry supplementation shows promise, particularly for acute glycemic control and ocular surface health, but larger long-term randomized trials using standardized formulations are needed before definitive clinical recommendations can be made. Full article

Interactions between resveratrol and biological or carrier systems play a key role in determining its bioavailability, stability, and delivery performance. These interactions involve proteins, lipids, cyclodextrins, nucleic acids, polysaccharides, and other formulation matrices, and are governed by noncovalent forces such as hydrogen bonding, hydrophobic interactions, π–π stacking, and desolvation effects. This review examines how complementary spectroscopic, calorimetric, structural, and computational techniques are used to characterize resveratrol interactions. Fluorescence, UV–visible spectroscopy, circular dichroism, FTIR, NMR, ITC, DSC, X-ray diffraction, molecular docking, and molecular dynamics simulations are discussed according to their contribution to binding analysis, conformational assessment, thermodynamic interpretation, structural organization, and complex stability. By integrating these approaches, this review provides a technique-oriented framework for understanding resveratrol binding and guiding the development of more stable resveratrol-based carrier systems and bioactive formulations. Full article

This study developed a complex functional ingredient based on beef offal paste, whey, rapeseed and sunflower cake powder, and flax flour, and evaluated its effect on beef cutlets formulated with 0, 5, 10, and 15% additive. The study examined chemical composition, pH, water activity, functional and technological properties, color, fatty acid profile, texture, sensory quality, and refrigerated storage stability. The additive improved the nutritional profile of the cutlets by increasing the protein content from 16.20% in the control to 17.78% at the highest inclusion level, while reducing fat content from 12.50% to 11.20%. The lipid fraction also became more favorable, as total polyunsaturated fatty acids increased from 7.03% to 13.34%, and α-linolenic acid appeared only in additive-containing samples. The additive also modified the functional and structural characteristics of the products. The 10% formulation showed the most pronounced improvement in texture, with the highest hardness, gumminess, and chewiness values, while sensory quality remained comparable to the control at 5 and 10% inclusion but declined at 15%. During 7 days of refrigerated storage, additive-containing samples showed lower acid and peroxide values than the control, together with a slight reduction in microbial growth. Overall, the developed additive acted as a multifunctional ingredient that improved nutritional and technological quality. Among the tested formulations, the 10% inclusion level provided the best balance between quality, storage stability, and sensory acceptability. Full article

Matcha, a finely milled powdered green tea originating from Japan, is characterized by a unique cultivation method in which tea plants are shaded prior to harvest. This practice enhances the accumulation of chlorophyll, caffeine, L-theanine, and other bioactive compounds. In addition, specialized post-harvest processing, including careful hand-picking, gentle steaming, drying, and traditional stone grinding, helps preserve the nutritional and biochemical integrity of the tea leaves. This review examines the relationship between cultivation and processing techniques and the resulting bioactive composition of matcha. It also summarizes current scientific evidence regarding the potential health-promoting properties of matcha and its major constituents. The analysis is based on available scientific literature, including both in vitro and in vivo studies investigating the biological activity of matcha and green tea catechins. Particular attention is given to studies evaluating their effects on metabolic parameters such as glucose levels, lipid profile, body weight regulation, and gut microbiota composition. In addition, the potential influence of matcha-derived compounds on neurological function, systemic physiological processes and anticancer potential is discussed. Furthermore, matcha is increasingly recognized as a functional food ingredient and has been incorporated into a variety of products, including bakery goods, dairy products, functional beverages, and nutraceutical formulations. The collected findings suggest that matcha may exert a broad spectrum of beneficial biological effects due to its high concentration of polyphenols, amino acids, and antioxidants. Nevertheless, despite promising experimental and preclinical data, further well-designed clinical studies are needed to better understand the mechanisms of action, bioavailability, and long-term health effects associated with regular matcha consumption. Full article

Background/Objectives: The blood–brain barrier (BBB) presents a major challenge for delivering therapeutics to the central nervous system (CNS) due to its highly selective permeability. Human brain microvascular endothelial cells (hBMECs), the principal cellular component of the BBB, tightly regulate molecular transport and restrict the entry of many CNS-targeted therapies. Lipid-based nanoparticles have emerged as promising carriers for BBB transport because of their biocompatibility, tunable surface properties, and cargo encapsulation capabilities. One strategy to enhance nanoparticle transport involves surface functionalization with ligands that exploit endogenous transcytosis pathways. Mannose-6-phosphate (M6P), a glycan implicated in the brain entry of certain proteins and viruses, represents a potential targeting ligand for this purpose. Methods: In this study, we established a physiologically relevant in vitro BBB model using human-induced pluripotent stem cell-derived brain microvascular endothelial cells (hiPSC-BMECs) to evaluate M6P-functionalized liposomes for BBB transport. Fluorophore-labeled liposomes were used to monitor nanoparticle uptake and transcytosis. Results: M6P-functionalized liposomes exhibited significantly enhanced uptake in hiPSC-BMECs compared with non-functionalized control liposomes. Pharmacological inhibition studies supported the involvement of a clathrin-sensitive endocytic pathway. Transcytosis assays demonstrated enhanced BBB crossing of M6P-functionalized liposomes, with transport increasing according to ligand density and reaching approximately 55% of the transport observed for transferrin under the same experimental conditions. Following transcytosis, intact M6P-functionalized liposomes showed significantly higher uptake by downstream hiPSC-derived neurons and astrocytoma cells compared with control formulations. Conclusions: Together, these findings support M6P-functionalization as a promising strategy to enhance liposome uptake and transcytosis across a human-relevant in vitro BBB model. This work provides a proof-of-concept framework for the development and optimization of glycan-functionalized nanocarriers for CNS-directed delivery. Full article

Metabolic dysfunction-associated steatotic liver disease (MASLD) has replaced older exclusion-based terminology as the preferred term for steatotic liver disease associated with cardiometabolic risk factors. MASLD is now among the most common causes of chronic liver disease and may progress from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and hepatocellular carcinoma. This updated rigorous narrative review synthesizes current evidence on MASLD diagnosis and management, with emphasis on the gut–liver axis and the therapeutic potential of combining probiotics with metformin. A structured narrative search was conducted in PubMed, PMC, ScienceDirect, Taylor & Francis, Cochrane Library, and Google Scholar using the keywords “MASLD”, “MAFLD”, “NAFLD”, “MASH”, “probiotics”, “synbiotics”, “metformin”, and “gut-liver axis”. The review was designed as a narrative synthesis rather than a systematic review. Current guidance supports stepwise risk stratification using serum fibrosis scores followed by elastography or advanced imaging when indicated. Ultrasonography remains accessible but has limited sensitivity for mild steatosis, is operator-dependent, and is not sufficient for comprehensive assessment of fibrosis or disease activity. Metformin is appropriate for type 2 diabetes mellitus and improves insulin resistance, but current guidelines do not recommend it as a targeted treatment for MASH because histological benefit has not been consistently demonstrated. Probiotics and synbiotics may improve aminotransferases, inflammatory markers, lipid parameters, intestinal barrier function, and gut dysbiosis; however, findings vary by strain, formulation, dose, treatment duration, population, and endpoint. The combination of probiotics and metformin is mechanistically plausible because it targets both metabolic dysfunction and intestinal dysbiosis, but human evidence remains limited. Larger, strain-specific, adequately powered trials using standardized MASLD criteria and clinically meaningful endpoints are required before routine clinical recommendations. Full article

Background: Platinum-based chemotherapy, including cisplatin and carboplatin, is widely used to treat various cancers, including ovarian cancer. However, its clinical application is limited by dose-limiting toxicities and resistance, with a poor 5-year overall survival rate for ovarian cancer (35–40%). In this study, we used ionisable lipids and developed pH-responsive lipid nanoparticles (LNPs) to address platinum-resistance in ovarian carcinoma. Methods: Cisplatin was loaded into three LNP systems containing monoolein (MO) and synthetic cationic ionisable lipids (OE-Mo, OA-Py, and OA-Pi) dispersed in Pluronic F-127 with 0.9% NaCl. Cisplatin-loaded LNPs (Cis-OE-Mo-NP, Cis-OA-Py-NP, and Cis-OA-Pi-NP) were characterised for size, zeta potential, and internal mesophase structure. Encapsulation efficiencies were determined via HPLC after removing free drug by ultrafiltration. In vivo efficacy was tested using cisplatin-resistant human patient-derived xenograft (PDX) models. Results: The LNPs were well dispersed with particle size of 219–250 nm and a drug loading of ~1.2 mg/mL. Encapsulation efficiencies were 62%, 59%, and 64%, for Cis-OE-Mo-NP, Cis-OA-Py-NP, and Cis-OA-Pi-NP, respectively. Small angle X-ray scattering (SAXS) results showed that the LNPs are pH responsive with structural transitions from a cubic to a hexagonal phase at an acidic pH. Among the tested formulations, Cis-OA-Py-NP resulted in the most significant reduction in tumour volume by ~60% compared to treatment with cisplatin alone. However, they also showed significant toxicity, including >10% weight loss and gross lung and kidney damage, as confirmed by histology. Conclusions: These findings highlight the potential of Cis-OA-Py-NP in reducing tumour volume but underscore the need for further optimisation to improve safety and therapeutic applicability. Full article

The low water solubility of numerous drug candidates and phytochemicals continues to pose a significant challenge in pharmaceutical development, greatly limiting their bioavailability and therapeutic performance. This review presents a detailed overview of formulation strategies aimed at improving the solubility and dissolution of poorly aqueous-soluble compounds. The biopharmaceutics classification system and the relevance of in vitro–in vivo correlation, as well as key challenges in formulation development, are briefed. Solid-state and particle engineering approaches, including micronization, supercritical fluid technology, electrospinning, and cryogenic techniques, are discussed. Extensive critical examination of amorphous solid dispersions and their preparation methods, as well as crystallization inhibition strategies, is covered. Cocrystallization is highlighted as a promising approach, with emphasis on design principles and preparation methods. Various solubilization techniques, such as pH modification, cosolvency, hydrotropy, micellar solubilization, and cyclodextrin-based complexation, including advanced hybrid systems, are also explored. Emerging solvent platforms, such as deep eutectic systems and lipid-based and nanotechnology-driven approaches, are reviewed for their role in improving solubility and drug delivery. Additionally, enabling technologies such as liquisolid systems and hydrophilic polymers are addressed. Despite notable progress, limitations such as scalability, reproducibility, regulatory constraints, and long-term safety persist. Overall, this review provides integrated insights into formulation design approaches to enhance the solubility and therapeutic efficacy of poorly soluble drugs. Full article

This study evaluated the effects of alternative feed formulations on the proximate composition and lipid quality of gilthead sea bream (Sparus aurata) in a long-term feeding trial (May 2022–September 2023). Three isoenergetic and isoproteic diets were tested in replicate tanks: a fishmeal-based control (CTRL), a processed animal protein–based diet (PAP), and a diet including insect meal and microalgae oil (ALT). Diet pellet sizes were adapted to the fishes’ developmental stage. Proximate composition and fatty acid profiles were assessed in feed and in fish fillets, with 20 fish analyzed per dietary treatment. The human health lipid indices of the fillets were calculated. Virtual diets were reconstructed to estimate theoretical fatty acid intake across growth, based on feed composition and consumption. Partial least squares discriminant analysis (PLS-DA) revealed distinct clustering by diet. Fillets from all diets met European Food Safety Authority criteria for being high in omega-3 fatty acids, with some variation in EPA and DHA concentrations among formulations. The ALT diet showed a 15% higher EPA+DHA content and the greatest fish lipid quality (FLQ) values, even having the lowest polyunsaturated fatty acids (PUFA) intake from feed, partly due to its elevated lauric acid (C12:0) content, which may contribute to rapid energy mobilization and omega-3 preservation. PAP-fed fish showed the most balanced PUFA/SFA and n6/n3 ratios. These findings demonstrate the viability of sustainable feed alternatives for maintaining nutritional quality in gilthead sea bream, supporting aquaculture sustainability without compromising nutritional value. Full article

Development of innovative functional foods is a key sports nutrition strategy to enhance physical performance, support recovery, and promote overall health. Plant-based protein-rich products have emerged as a sustainable alternative to conventional animal-protein sources, offering nutritional benefits and reducing environmental impact. This study aimed to develop high-protein plant-based cookies using a conventional formulation enriched with carrot, broccoli, and legume flour, and to evaluate their effects in a preclinical model. The nutritional composition was determined using standard food analysis methods and microbiological assays were conducted to ensure safety. Twelve-week-old male Wistar rats were randomly assigned to either a standard diet group or a cookie-supplemented group. The intervention consisted of daily administration of cookies at a dose of 5.3 g/kg body weight for 15 days. Physiological and biochemical parameters, including body weight, glucose, lipid profile, renal function, muscle thickness, and grip strength, were assessed. Despite no significant differences in glucose and lipid profiles between groups, increased muscle thickness (pubococcygeus and gastrocnemius), improved grip strength and higher levels of urea and creatinine were observed in the supplemented group. These findings indicate that high-protein plant-based cookies are safe in preclinical conditions and may promote functional benefits such as enhanced muscle strength and lean mass development. Therefore, they represent a promising and sustainable functional food for sports nutrition applications. Full article

Boswellic acids (BAs), the major bioactive constituents of Boswellia serrata oleo–gum resin, exhibit well-documented anti-inflammatory and antioxidant activities, which correspond to their healing effects in arthritis, inflammatory bowel disease, asthma, metabolic syndrome, liver disorders, and certain cancers. However, their therapeutic potential is hindered by their poor aqueous solubility, low intestinal absorption, extensive metabolism, and overall low oral bioavailability. This review provides a comprehensive analysis of conventional Boswellia serrata products and advanced drug delivery systems designed to enhance the biological performance of BAs. We summarize recent developments in formulation strategies, including phytosomes, micelles, self-emulsifying drug delivery systems, solid lipid particles, polymeric nanoparticles, hydrogels, cyclodextrin complexes, metal-based nanocarriers, and hybrid delivery platforms. Available in vivo and cellular studies are critically evaluated, with a focus on disease-specific outcomes. Results indicate that emerging formulation technologies significantly increase the oral absorption, systemic exposure, and biological effectiveness of BAs. However, despite promising preclinical data, challenges remain regarding the standardization of Boswellia extracts, the stability of novel formulations, their safety, and limited clinical evaluation. By comparing the advantages and limitations of conventional preparations with modern drug delivery systems, this review outlines the most effective strategies to enhance the bioavailability of BAs and highlights future research directions for their translational development. Full article

(1) Background: Glyphosate (GLY) and glyphosate-based herbicides (GBHs) are widely used agrochemicals. Experimental studies have reported oxidative stress, inflammatory activation, mitochondrial impairment, endocrine-related effects, and organ injury following GLY/GBH exposure; however, candidate mitigation approaches have not been comprehensively summarized across experimental systems. (2) Methods: This structured narrative review followed SANRA recommendations. PubMed, Scopus, Web of Science, and Embase were searched (January 2004–January 2026). In total, 37 experimental studies met the inclusion criteria, describing 23 compounds categorized as vitamins, antioxidants, or enzyme modulators, dietary supplements, plant extracts, humic substances, hormonal modulators, and other natural compounds. (3) Results: Across models, reported protective effects most consistently involved attenuation of oxidative damage, including reductions in lipid peroxidation, oxidative DNA damage markers, and partial restoration of endogenous antioxidant defenses. Several interventions also modulated inflammatory signaling, apoptosis-associated markers, and stress response signaling. Protective effects were generally dose-dependent and more frequently observed in pre-treatment or co-exposure paradigms; complete normalization of outcomes was uncommon. Interpretation across studies was limited by heterogeneity in exposure conditions, test systems, endpoints, and, critically, by differences between pure GLY and GBHs. (4) Conclusions: Experimental evidence supports the mechanistic plausibility of antioxidant and stress response modulation as candidate approaches to mitigate GLY/GBH-induced toxicity. However, substantial methodological variability, frequent use of high-dose or non-representative exposure paradigms, and the absence of human interventional data limit translational relevance. Future studies should prioritize standardized, formulation-specific designs with exposure scenarios aligned to real-world conditions and include systematic safety assessment of proposed interventions. Full article

Marine macroalgae are a rich source of bioactive natural products, although the application of many lipophilic compounds is limited by poor aqueous solubility and instability. This study investigated metabolites isolated from the South African brown seaweed Sargassum incisifolium and evaluated a solid lipid nanoparticle (SLN) system to improve their physicochemical properties and enable bioactivity studies. Five metabolites, including one previously unreported derivative and four known metabolites (including fucoxanthin), were isolated and characterized using standard chromatographic and spectroscopic techniques. SLNs composed of stearic acid and Poloxamer 188 were prepared via hot homogenization and characterized using dynamic light scattering, scanning electron microscopy, thermogravimetric analysis, and NMR, which confirmed the efficient encapsulation of the lipophilic compounds. Antimicrobial activity against clinically relevant bacterial and fungal pathogens was evaluated using a resazurin-based microdilution assay, with results expressed as percentage growth relative to untreated controls. The pure compounds exhibited moderate, concentration-dependent activity, while the SLN formulations improved dispersibility, and in several cases, reduced % growth or produced more consistent responses, particularly against Gram-positive bacteria and Candida auris. Although activity remained lower than that of conventional antimicrobials, these findings demonstrate that SLN-based delivery enables functional evaluation of hydrophobic marine metabolites and supports further development of Sargassum-derived natural products. Full article